The company's headwinds don't seem to be going away.Shares of Teladoc Health (TDOC 5.68%), a telemedicine specialist, are down 8% year to date. The stock's performance is well below that of broader equities, but not as bad as what investors have become accustomed to in recent years. In fact, over the past six months, Teladoc has been on a bit of a run, gaining 21%. The company continues to struggle as it chases -- so far unsuccessfully -- the kind of success it achieved in 2020 and 2021. But could the teleh ...